
Ghanshyam Vinubhai Pansuriya
About Ghanshyam Vinubhai Pansuriya
Data last updated:
Ghanshyam Vinubhai Pansuriya is a Ceo at Aptus Pharma Limited (since 2025). The company operates in Trading. Aptus Pharma Limited reported revenue of ₹24.64 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Ceo | 01 Jan 2025 | 2010 | ₹24.64 Cr (FY 2025) | Active |
Board colleagues of Ghanshyam Vinubhai Pansuriya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Chetan Shantilal Lalseta | 02547012 | Aptus Pharma Limited | Director |
| Jyotiben Hasmukhbhai Chandarana | 10607059 | Aptus Pharma Limited | Director |
| Kapilbhai Hasmukhbhai Chandarana | Aptus Pharma Limited | Cfo | |
| Mohini Hardikbhai Gandhi | Aptus Pharma Limited | Company Secretary | |
| Riddhish Natwarlal Tanna | 03231612 | Aptus Pharma Limited | Director |
| Sejal Harit Palan | 10893463 | Aptus Pharma Limited | Director |
| Tejash Maheshchandra Hathi | 03151221 | Aptus Pharma Limited | Managing Director |
| Vikas Rambhai Jobanputra | 10921323 | Aptus Pharma Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ghanshyam Vinubhai Pansuriya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ghanshyam Vinubhai Pansuriya
Ghanshyam Vinubhai Pansuriya currently holds 1 directorship: Aptus Pharma Limited (Ceo, since 01 Jan 2025, revenue ₹24.64 Cr (FY 2025)).
Ghanshyam Vinubhai Pansuriya was first appointed on 01 Jan 2025 as Ceo at Aptus Pharma Limited.
The current boards of Ghanshyam Vinubhai Pansuriya's companies include Chetan Shantilal Lalseta (Aptus Pharma Limited), Jyotiben Hasmukhbhai Chandarana (Aptus Pharma Limited), Kapilbhai Hasmukhbhai Chandarana (Aptus Pharma Limited), Mohini Hardikbhai Gandhi (Aptus Pharma Limited), Riddhish Natwarlal Tanna (Aptus Pharma Limited), Sejal Harit Palan (Aptus Pharma Limited), among others.